FT. LAUDERDALE, Fla.–(BUSINESS WIRE)– #TRUEMETRIX–Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are preferred for commercial patients on the Express Scripts National Preferred Formulary in the United States, effective October 1st, 2025. The TRUE METRIX® portfolio provides a level of performance rooted in science, research and technological advancements. TRUE METRIX test strips feature TRIPLE SENSE TECHNOLOGY®, which ensures proven accuracy and confiden
administrator